You just read:

Concise Analysis of New Methods for Treating Refractory Hematological Malignancies - Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

News provided by

Research and Markets

26 Mar, 2014, 11:15 GMT